… despite a temporary revenue dip in the first quarter of FY26. … Q1 Revenue Dip ‘Temporary’, Says CFO The Mumbai-based pharmaceutical ingredients … will act rashly on pharma.” Global Strategy: Europe … the world’s largest pharma market,” Raghunathan remarked. …

… yuan loss in the first quarter of this year … profit margins of only 1.4% last year and in the first quarter … first quarter of this year, but contributed only 33% of overall revenue. Conversely, pharmaceutical … million yuan in the first quarter of this year. It …

1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics provides update on Bitcoin Treasury, …

… purchase of Russian oil. Pharmaceuticals, however, have so far … Q1 FY26 Results Sigachi Industries reported a consolidated net profit … of ₹13.26 crore for the first quarter of … profitability came despite a strong 23 per cent jump in revenue …

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Q1 2026 Earnings … discuss KalVista Pharmaceuticals fiscal year 2026 first quarter financial update … Piekos: In respect to revenue…sorry, go ahead. … now disconnect. Follow Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) …

… purchase of Russian oil. Pharmaceuticals, however, have so far … Q1 FY26 Results Sigachi Industries reported a consolidated net profit … of ₹13.26 crore for the first quarter of … profitability came despite a strong 23 percent jump in revenue …

… tariffs on New Delhi, pharmaceutical and nutraceutical companies remain … updates surrounding the deal, pharma stocks could perform well … place. Q1 performance snapshotIn Q1 FY26, Sigachi Industries posted revenue of … last year. Gross profit rose 15% year-on …

… pharma layoffs in 2025 reflects a broader efficiency drive, where even profitable … 000 roles in the first quarter alone, emphasizing reductions … biotech closures in Q1 dropping to four in … large for big pharma, eroding revenues and prompting restructurings. …

… strain, with large-cap pharmaceuticals and managed care bearing the … , expected to close in Q1 2026. This move aims … strong momentum in the Pharma segment, driven by rising … pharmaceutical clients. The biotechnology segment saw a 6% year-over-year revenue …

… for 89.6% of total revenue, increased by $0.4 … the prior year quarter.  Gross profit. Gross profit of $5.3 million … A conference call to discuss first quarter financial results for fiscal 2025 … 4,000 grocery stores and pharmacies, over 1,500 convenience stores …